首站-论文投稿智能助手
典型文献
Health-related quality of life and stress-related disorders in COVID-19 ICU survivors: Are they worse than with other causes of ARDS?
文献摘要:
Background::There are insufficient data regarding the impact of acute respiratory distress syndrome related to coronavirus disease 2019 (C-ARDS) - caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - on health-related quality of life (HRQoL) and the occurrence of stress-related disorders in coronavirus disease 2019 (COVID-19) intensive care unit (ICU) survivors. The aim of this study is to assess HRQoL and the occurrence of stress-related disorders (acute stress disorder [ASD] and post-traumatic stress disorder [PTSD]) in C-ARDS ICU survivors at 1 and 6 months following hospital discharge.Methods::This prospective observational study included 90 patients treated for C-ARDS between March and May 2020 in the ICU and discharged alive from the hospital. All patients included in the study were contacted by telephone 1 month and 6 months post-hospital discharge to assess the presence of symptoms of stress-related disorders and HRQoL using the 8-item Treatment Outcome Post-traumatic Stress Disorder scale (TOP-8) and 36-item Short Form survey (SF-36). We performed univariate analyses to evaluate differences between patients who developed stress and those who did not. We also compared SF-36 scores in our sample with data from the general Spanish population and from cohorts of non-C-ARDS and severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) survivors.Results::There are 24.1% of patients showed symptoms of ASD; in 13.5% of cases the symptoms persisted 6 months later. Risk factors for the development of symptoms of ASD and PTSD are younger age, female sex, obesity, a previously diagnosed psychiatric disease and disease severity at ICU admission ( P < 0.05). HRQoL was greatly affected by C-ARDS; however, there was improvement on all scales of the SF-36 at the 6-month follow-up ( P < 0.05). The mean SF-36 score of our sample was higher than those previously reported in non-C-ARDS survivors ( P < 0.05) for physical functioning (78.0 vs. 52.0), role functioning/physical (51.0 vs. 31.0), bodily pain (76.1 vs. 57.0), vitality (58.6 vs. 48.0), social function (72.6 vs. 63.0) and role emotional (77.4 vs. 55.0), except on the general health scale. C-ARDS survivors also scored better than SARS-CoV-1 survivors on all scales except for body pain ( P < 0.05). Conclusions::The impact of C-ARDS on HRQoL is substantial, with frequent occurrence of PTSD symptoms. Patients are heavily affected in all areas of health in the first month of post-hospital discharge but show a dramatic improvement within 6 months, especially in terms of physical health.
文献关键词:
COVID-19;Post-intensive care syndrome;Respiratory distress syndrome, Adult;Health-related quality of life;Post-traumatic stress disorder
作者姓名:
Gil Diego;Tiscar Carlos;Gómez Maria;Felices Javier;Gajate Luis;Fernandez Patricia;Pesta?a David;Bardi Tommaso
作者机构:
Department of Anaesthesiology and Critical Care, Ramón y Cajal Hospital, 28034 Madrid, Spain;Department of Psychology, Ramón y Cajal Hospital, 28034 Madrid, Spain
引用格式:
[1]Gil Diego;Tiscar Carlos;Gómez Maria;Felices Javier;Gajate Luis;Fernandez Patricia;Pesta?a David;Bardi Tommaso-.Health-related quality of life and stress-related disorders in COVID-19 ICU survivors: Are they worse than with other causes of ARDS?)[J].重症医学(英文),2022(02):103-109
A类:
B类:
Health,related,quality,life,disorders,ICU,survivors,Are,they,worse,than,other,causes,ARDS,Background,There,insufficient,data,regarding,impact,acute,respiratory,distress,syndrome,coronavirus,disease,caused,by,severe,SARS,CoV,health,HRQoL,occurrence,intensive,care,unit,aim,this,study,assess,ASD,post,traumatic,PTSD,months,following,hospital,Methods,This,prospective,observational,included,patients,treated,between,March,May,discharged,alive,from,All,were,contacted,telephone,presence,symptoms,using,item,Treatment,Outcome,Post,Stress,Disorder,TOP,Short,Form,survey,SF,We,performed,univariate,analyses,evaluate,differences,who,developed,those,did,not,also,compared,scores,our,sample,general,Spanish,population,cohorts,Results,showed,cases,persisted,later,Risk,factors,development,younger,age,female,sex,obesity,previously,diagnosed,psychiatric,severity,admission,was,greatly,affected,however,there,improvement,scales,up,mean,higher,reported,physical,functioning,role,bodily,pain,vitality,social,emotional,except,scored,better,body,Conclusions,substantial,frequent,Patients,heavily,areas,first,but,dramatic,within,especially,terms,Respiratory,Adult
AB值:
0.455329
相似文献
The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level
Zheng Jin-Xin;Lv Shan;Tian Li-Guang;Guo Zhao-Yu;Zheng Pei-Yong;Chen Yue-Lai;Guan Shi-Yang;Wang Wei-Ming;Zhang Shun-Xian-Department of Nephrology, Ruijin Hospital, Institute of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People’s Republic of China;Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai 200025, People’s Republic of China;Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, People’s Republic of China;Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, People’s Republic of China;School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People’s Republic of China;One Health Center, Shanghai Jiao Tong University–The University of Edinburgh, Shanghai 200025, People’s Republic of China
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Homeopathy for COVID-19 in primary care:A randomized,double-blind,placebo-controlled trial(COVID-Simile study)
Ubiratan Cardinalli Adler;Maristela Schiabel Adler;Ana Elisa Madureira Padula;Livia Mitchiguian Hotta;Amarilys de Toledo Cesar;José Nelson Martins Diniz;Helen de Freitas Santos;Edson Zangiacomi Martinez-Department of Medicine,Federal University of S?o Carlos,S?o Carlos 13565-905,Brazil;Homeopathy Solidarity Outpatient Extension Program,Mackenzie Presbyterian University,S?o Paulo 01302-907,Brazil;Municipal Center for Integrative and Complementary Practices in Health,Guarulhos 07023-051,Brazil;HN-Cristiano Institute,S?o Paulo 02013-001,Brazil;School Health Unit,Federal University of S?o Carlos,Sao Carlos 13565-905,Brazil;Federal Institute of Education,Science and Technology of S?o Paulo,Birigui 16201-407,Brazil;Department of Social Medicine,Ribeir?o Preto Medical School,University of Sao Paulo,Ribeirao Preto 14049-900,Brazil
Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients
Jiang Nan;Li Qin;Li Hongbin;Fang Yongfei;Wu Lijun;Duan Xinwang;Xu Jian;Zhao Cheng;Jiang Zhenyu;Wang Yanhong;Wang Qian;Leng Xiaomei;Li Mengtao;Tian Xinping;Zeng Xiaofeng;CREDIT Co-Authors-Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China;Department of Rheumatology, the First People’s Hospital of Yunnan Province, Kunming, Yunnan 650032, China;Department of Rheumatology, the Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, China;Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China;Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China;Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China;Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China;Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China;Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China;Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China
Establishment and Evaluation of a Prediction Model of BLR for Severity in Coronavirus Disease 2019
He Zebao;Rui Fajuan;Yang Hongli;Ge Zhengming;Huang Rui;Ying Lingjun;Zhao Haihong;Wu Chao;Li Jie-Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, Zhejiang 317099, China;Department of Infectious Diseases, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang 318053, China;Department of Infectious Disease, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong 250021, China;Department of Infectious Disease, Cheeloo College of Medicine, Shandong University, Ji’nan, Shandong 250012, China;Department of Infectious Diseases, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, China;Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu 210033, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。